Beijing SL Pharmaceutical Statistics

Total Valuation

SHE:002038 has a market cap or net worth of CNY 6.89 billion. The enterprise value is 6.12 billion.

Market Cap	6.89B
Enterprise Value	6.12B

Important Dates

The next estimated earnings date is Monday, August 25, 2025.

Earnings Date	Aug 25, 2025
Ex-Dividend Date	Jul 4, 2024

Share Statistics

SHE:002038 has 1.03 billion shares outstanding. The number of shares has increased by 7.94% in one year.

Current Share Class	1.03B
Shares Outstanding	1.03B
Shares Change (YoY)	+7.94%
Shares Change (QoQ)	-0.26%
Owned by Insiders (%)	23.31%
Owned by Institutions (%)	3.00%
Float	628.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.80
PB Ratio	1.23
P/TBV Ratio	1.41
P/FCF Ratio	n/a
P/OCF Ratio	109.86
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 58.70, with an EV/FCF ratio of -15.67.

EV / Earnings	-62.27
EV / Sales	10.47
EV / EBITDA	58.70
EV / EBIT	n/a
EV / FCF	-15.67

Financial Position

The company has a current ratio of 7.67

Current Ratio	7.67
Quick Ratio	2.70
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -1.73% and return on invested capital (ROIC) is -0.55%.

Return on Equity (ROE)	-1.73%
Return on Assets (ROA)	-0.51%
Return on Invested Capital (ROIC)	-0.55%
Return on Capital Employed (ROCE)	-0.88%
Revenue Per Employee	682,476
Profits Per Employee	-114,757
Employee Count	856
Asset Turnover	0.09
Inventory Turnover	0.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.68% in the last 52 weeks. The beta is 0.36, so SHE:002038's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-14.68%
50-Day Moving Average	6.65
200-Day Moving Average	7.07
Relative Strength Index (RSI)	58.82
Average Volume (20 Days)	9,467,688

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:002038 had revenue of CNY 584.20 million and -98.23 million in losses. Loss per share was -0.09.

Revenue	584.20M
Gross Profit	361.88M
Operating Income	-50.65M
Pretax Income	-156.88M
Net Income	-98.23M
EBITDA	104.20M
EBIT	-50.65M
Loss Per Share	-0.09

Full Income Statement

Balance Sheet

The company has 784.84 million in cash and n/a in debt, giving a net cash position of 784.84 million or 0.76 per share.

Cash & Cash Equivalents	784.84M
Total Debt	n/a
Net Cash	784.84M
Net Cash Per Share	0.76
Equity (Book Value)	5.63B
Book Value Per Share	4.89
Working Capital	2.23B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 62.75 million and capital expenditures -453.14 million, giving a free cash flow of -390.39 million.

Operating Cash Flow	62.75M
Capital Expenditures	-453.14M
Free Cash Flow	-390.39M
FCF Per Share	-0.38

Full Cash Flow Statement

Margins

Gross margin is 61.94%, with operating and profit margins of -8.67% and -16.81%.

Gross Margin	61.94%
Operating Margin	-8.67%
Pretax Margin	-26.85%
Profit Margin	-16.81%
EBITDA Margin	17.84%
EBIT Margin	-8.67%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 2.21%.

Dividend Per Share	0.15
Dividend Yield	2.21%
Dividend Growth (YoY)	50.00%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-7.94%
Shareholder Yield	-5.73%
Earnings Yield	-1.42%
FCF Yield	-5.66%

Dividend Details

Stock Splits

The last stock split was on July 4, 2019. It was a forward split with a ratio of 1.5.

Last Split Date	Jul 4, 2019
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a